SANTA CLARA, CA and WEST SACRAMENTO, CA -- (MARKET WIRE) -- February 12, 2007 -- Agilent Technologies Inc. (NYSE: A) and Lipomics Technologies Inc. today announced that they will collaborate to develop research and diagnostic assays combining Agilent analytical platforms with Lipomics' expertise in biomarker discovery and validation.
